Dr Himanshu's Clinic, Delhi Gate, Agra +91 8171944038 WhatsApp Mon–Fri 08:00–21:00 · Sat–Sun 09:00–20:00
Book Appointment
Colorectal Cancer

Business WireMerck Expands Colorectal Cancer Portfolio Through License Agreement with Inspirna First-in-class ompenaclide (RGX-202) is currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer. .17 hours ago

Business WireMerck Expands Colorectal Cancer Portfolio Through License Agreement with Inspirna First-in-class ompenaclide (RGX-202) is currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer. .17 hours ago

📅 Published: January 15, 2024 👨‍⚕️ By: Nisha
Medical Article Header
ℹ️
Article Information & Medical Note This article provides general educational information published on January 15, 2024 by Nisha. It is not a substitute for individual medical advice.